Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CytoDyn said updated data from its Phase 2 CLOVER study will be presented at the ESMO Congress 2026 in Madrid. The study is evaluating leronlimab with trifluridine/tipiracil and bevacizumab in previously treated metastatic colorectal cancer.
CytoDyn said it will present updated data from its Phase 2 CLOVER clinical study at the 2026 ESMO Congress.